NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
This grant will invite eligible US small businesses to apply for SBIR funding from NIH, CDC, and FDA for innovative research projects, but clinical trials are not allowed and applications are not yet open.
Funder: National Institutes of Health
Due Dates: April 5, 2027: Full application submission deadline
Funding Amounts: Award ceiling and floor not specified; funding typically supports feasibility studies and R&D for product commercialization.
Summary: Supports U.S. small businesses in bringing scientific innovations to market through feasibility and R&D funding.
Key Information: Only U.S. small business concerns (SBCs) are eligible; foreign organizations are not eligible.
Description
The Small Business Innovation Research (SBIR) program, administered by the National Institutes of Health (NIH), helps U.S. small business concerns (SBCs) translate scientific innovations into commercial products. This parent SBIR opportunity (R43/R44, Clinical Trial Optional) funds both feasibility studies and subsequent research and development (R&D) to support the commercialization of new products with potential public health impact. The program covers a broad range of health-related research areas, including but not limited to chronic diseases, environmental health, infectious diseases, biomedical technology, and mental health.
